One of Canada’s largest cannabis companies announced Wednesday it has received Health Canada approval for clinical trials of the effectiveness of cannabis-derived compound cannabidiol as a treatment for anxiety in animals. Dana M. Vaughn, executive vice-president and chief scientific officer for Canopy Animal Health, said while CBD is becoming an increasingly common folk remedy for pets’ ailments, Canopy’s clinical trials represent the first time a company has sought federal regulatory approval for the practice of…